Gynem s.r.o.
- Address
- lock Available on a paid plan
Female Urogenital Diseases and Pregnancy Complications
The Gynem Fertility Clinic is conducting exploratory research focused on infertility in women undergoing assisted reproductive technologies (ART). The studies aim to evaluate how the investigational agent FE 999302 interacts with follitropin delta during controlled ovarian stimulation, seeking to improve treatment outcomes and optimize protocol timing.
- Investigating the safety and efficacy of FE 999302 as an adjunct to follitropin delta
- Assessing the impact of different administration schedules on ovarian response
- Exploring biomarkers for predicting successful stimulation cycles
These trials reflect Gynem s.r.o.'s commitment to advancing reproductive health solutions in Prague.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ferring Pharmaceuticals A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gynem s.r.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Exploratory Study on the Effects of FE 999302 During Controlled Ovarian Stimulation with Follitropin Delta in Women Undergoing ART for Infertility | Ferring Pharmaceuticals A/S | Phase I | Not Recruiting | Jul 2024 | Sep 2025 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.